首页>
外国专利>
COMBINATION THERAPY COMPRISING A CCR5 ANTAGONIST,A HIV-1 PROTEASE INHIBITOR AND A PHARMACOKINETIC ENHANCER
COMBINATION THERAPY COMPRISING A CCR5 ANTAGONIST,A HIV-1 PROTEASE INHIBITOR AND A PHARMACOKINETIC ENHANCER
展开▼
机译:包含CCR5拮抗剂,HIV-1蛋白酶抑制剂和药代动力学增强剂的联合治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention discloses a novel combination therapy for HIV-1 treatment relying on a combination of at least one CCR5 antagonist, at least one HIV-1 protease inhibitor and at least one pharmacokinetic enhancer of said at least one CCR5 antagonist and/or at least one HIV-1 protease inhibitor. The combination is intended for use in oral treatment of a disorder selected from the group consisting of HIV-1 infection, retroviral infections genetically related to HIV and AIDS, in a treatment-naïve patient infected with CCR5 tropic HIV-1 virus.
展开▼